Literature DB >> 16601897

X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype.

I A Anselm1, I M Anselm, F S Alkuraya, G S Salomons, C Jakobs, A B Fulton, M Mazumdar, M Rivkin, R Frye, T Young Poussaint, D Marsden.   

Abstract

We report two unrelated boys with the X-linked creatine transporter defect (CRTR) and clinical features more severe than those previously described with this disorder. These two boys presented at ages 12 and 30 months with severe mental retardation, absent speech development, hypotonia, myopathy and extra-pyramidal movement disorder. One boy has seizures and some dysmorphic features; he also has evidence of an oxidative phosphorylation defect. They both had classical absence of creatine peak on brain magnetic resonance spectroscopy (MRS). In one, however, this critical finding was overlooked in the initial interpretation and was discovered upon subsequent review of the MRS. Molecular studies showed large genomic deletions of a large part of the 3' end of the complete open reading frame of the SLC6A8 gene. This report emphasizes the importance of MRS in evaluating neurological symptoms, broadens the phenotypic spectrum of CRTR and adds knowledge about the pathogenesis of creatine depletion in the brain and retina.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601897      PMCID: PMC2393549          DOI: 10.1007/s10545-006-0123-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  25 in total

1.  On the mechanisms of neuroprotection by creatine and phosphocreatine.

Authors:  N Brustovetsky; T Brustovetsky; J M Dubinsky
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

2.  The clinical syndrome of creatine transporter deficiency.

Authors:  Ton J deGrauw; Kim M Cecil; Anna W Byars; Gajja S Salomons; William S Ball; Cornelis Jakobs
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

Review 3.  Creatine deficiency syndromes.

Authors:  Andreas Schulze
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

4.  Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders.

Authors:  Deyanira Corzo; William Gibson; Kisha Johnson; Grant Mitchell; Guy LePage; Gerald F Cox; Robin Casey; Carolyn Zeiss; Heidi Tyson; Garry R Cutting; Gerald V Raymond; Kirby D Smith; Paul A Watkins; Ann B Moser; Hugo W Moser; Steven J Steinberg
Journal:  Am J Hum Genet       Date:  2002-04-29       Impact factor: 11.025

Review 5.  Inborn errors of creatine metabolism and epilepsy: clinical features, diagnosis, and treatment.

Authors:  Vincenzo Leuzzi
Journal:  J Child Neurol       Date:  2002-12       Impact factor: 1.987

6.  Rod photoreceptor function in children with mitochondrial disorders.

Authors:  Linda L Cooper; Ronald M Hansen; Basil T Darras; Mark Korson; Frances E Dougherty; John M Shoffner; Anne B Fulton
Journal:  Arch Ophthalmol       Date:  2002-08

Review 7.  Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism.

Authors:  C Stromberger; O A Bodamer; S Stöckler-Ipsiroglu
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 8.  X-linked creatine transporter defect: an overview.

Authors:  G S Salomons; S J M van Dooren; N M Verhoeven; D Marsden; C Schwartz; K M Cecil; T J DeGrauw; C Jakobs
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

9.  Development of ERG responses: the ISCEV rod, maximal and cone responses in normal subjects.

Authors:  Anne B Fulton; Ronald M Hansen; Carol A Westall
Journal:  Doc Ophthalmol       Date:  2003-11       Impact factor: 2.379

10.  High prevalence of SLC6A8 deficiency in X-linked mental retardation.

Authors:  Efraim H Rosenberg; Ligia S Almeida; Tjitske Kleefstra; Rose S deGrauw; Helger G Yntema; Nadia Bahi; Claude Moraine; Hans-Hilger Ropers; Jean-Pierre Fryns; Ton J deGrauw; Cornelis Jakobs; Gajja S Salomons
Journal:  Am J Hum Genet       Date:  2004-05-20       Impact factor: 11.025

View more
  18 in total

1.  Expression and distribution of creatine transporter and creatine kinase (brain isoform) in developing and mature rat cochlear tissues.

Authors:  Ann Chi Yan Wong; Sailakshmi Velamoor; Matthew R Skelton; Peter R Thorne; Srdjan M Vlajkovic
Journal:  Histochem Cell Biol       Date:  2012-02-04       Impact factor: 4.304

2.  Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect.

Authors:  Vassili Valayannopoulos; Nathalie Boddaert; Allel Chabli; Valerie Barbier; Isabelle Desguerre; Anne Philippe; Alexandra Afenjar; Michel Mazzuca; David Cheillan; Arnold Munnich; Yves de Keyzer; Cornelis Jakobs; Gajja S Salomons; Pascale de Lonlay
Journal:  J Inherit Metab Dis       Date:  2011-06-10       Impact factor: 4.982

Review 3.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

4.  Comparative expression analysis of the phosphocreatine circuit in extant primates: Implications for human brain evolution.

Authors:  Adam D Pfefferle; Lisa R Warner; Catrina W Wang; William J Nielsen; Courtney C Babbitt; Olivier Fedrigo; Gregory A Wray
Journal:  J Hum Evol       Date:  2010-12-28       Impact factor: 3.895

Review 5.  Creatine transporter deficiency in two adult patients with static encephalopathy.

Authors:  A Sempere; C Fons; A Arias; P Rodríguez-Pombo; R Colomer; B Merinero; P Alcaide; A Capdevila; A Ribes; R Artuch; J Campistol
Journal:  J Inherit Metab Dis       Date:  2009-03-25       Impact factor: 4.982

Review 6.  Mental retardation and inborn errors of metabolism.

Authors:  A García-Cazorla; N I Wolf; M Serrano; U Moog; B Pérez-Dueñas; P Póo; M Pineda; J Campistol; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2009-08-14       Impact factor: 4.982

Review 7.  AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review.

Authors:  O Braissant; H Henry
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

8.  1H MR spectroscopy as a diagnostic tool for cerebral creatine deficiency.

Authors:  Monika Dezortova; Filip Jiru; Jan Petrasek; Vera Malinova; Jiri Zeman; Milan Jirsa; Milan Hajek
Journal:  MAGMA       Date:  2008-08-26       Impact factor: 2.310

9.  Neuropsychological profile and clinical effects of arginine treatment in children with creatine transport deficiency.

Authors:  Annamaria Chilosi; Manuela Casarano; Alessandro Comparini; Francesca Maria Battaglia; Margherita Maria Mancardi; Cristina Schiaffino; Michela Tosetti; Vincenzo Leuzzi; Roberta Battini; Giovanni Cioni
Journal:  Orphanet J Rare Dis       Date:  2012-06-19       Impact factor: 4.123

10.  Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency.

Authors:  Matthew R Skelton; Tori L Schaefer; Devon L Graham; Ton J Degrauw; Joseph F Clark; Michael T Williams; Charles V Vorhees
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.